Bio-Techne Corp. (TECH) Valuation
Historical valuation analysis based on 500 data points (2024-08-30 to 2026-08-28)
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein s...
Bio-Techne Corp. (TECH) currently trades at a P/E ratio of 103.79 (historical range: 56.33–137.95, median: 77.37), placing it at the 78th percentile — above its historical average, P/S ratio of 9.39 (range: 5.61–11.19, 78th percentile — above its historical average), EV/EBITDA of 63.97 (range: 38.21–324.87, 28th percentile).
Over the historical period (2024-08-30 to 2026-08-28), Bio-Techne Corp.'s P/E ratio has expanded by 48% over the observed period (from an average of 68.3 to 101.4).
Bio-Techne Corp. appears slightly overvalued relative to its historical range, with most valuation metrics above their median levels.
Historical Valuation Metrics
| Metric | Current | Min | Median | Max | Percentile | Assessment |
|---|---|---|---|---|---|---|
| P/E Ratio | 103.79 | 56.33 | 77.37 | 137.95 | 78th | above its historical average |
| P/S Ratio | 9.39 | 5.61 | 7.78 | 11.19 | 78th | above its historical average |
| EV/EBITDA | 63.97 | 38.21 | 86.66 | 324.87 | 28th | below its historical average |
| FCF Yield | 0.02 | 0.00 | 0.02 | 0.03 | 50th | near its historical average |